Published in Br J Cancer on October 02, 2007
Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form. Structure (2015) 1.43
Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer (2009) 1.12
Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol (2012) 1.11
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Mol Cancer (2015) 1.04
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles. Cell Adh Migr (2010) 0.93
Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers. FEBS Open Bio (2015) 0.92
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue. Virchows Arch (2009) 0.92
Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene (2012) 0.90
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. Cancer Sci (2014) 0.89
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3. Breast Cancer Res (2014) 0.87
Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling. PLoS One (2013) 0.86
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma. Onco Targets Ther (2016) 0.84
Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3. PLoS One (2010) 0.84
Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. PLoS One (2012) 0.84
Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development (2011) 0.84
Impact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. PLoS One (2013) 0.84
Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). PLoS One (2015) 0.84
Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis. Am J Physiol Heart Circ Physiol (2014) 0.81
Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer. Oncotarget (2015) 0.81
The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. J Exp Clin Cancer Res (2009) 0.81
Differential expression of neurogenes among breast cancer subtypes identifies high risk patients. Oncotarget (2016) 0.78
The non-canonical role of vascular endothelial growth factor-C axis in cancer progression. Exp Biol Med (Maywood) (2015) 0.77
Role of vascular endothelial growth factor receptor-3/Flt-4 in early-stage cervical cancer. Oncol Lett (2010) 0.76
Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo. Oncol Lett (2015) 0.75
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 5.33
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res (2005) 4.38
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J (2001) 3.88
The role of neuropilins in cancer. Mol Cancer Ther (2006) 2.28
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood (2001) 2.27
Biology of vascular endothelial growth factors. FEBS Lett (2006) 2.26
Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res (2002) 2.20
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol (2004) 2.13
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest (2000) 2.08
Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res (2003) 1.95
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood (2006) 1.88
Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol (1993) 1.82
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J (2006) 1.79
Tumor and lymph node lymphangiogenesis--impact on cancer metastasis. J Leukoc Biol (2006) 1.72
The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem (2004) 1.69
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest (2003) 1.51
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat (2005) 1.47
Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res (2005) 1.44
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol (2001) 1.41
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer (2006) 1.39
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Exp Cell Res (2003) 1.36
The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol Biol Cell (2001) 1.35
Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin Cancer Res (2006) 1.31
The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett (2006) 1.30
Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun (2001) 1.27
Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat (2001) 1.24
VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery (2006) 1.24
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes. Clin Exp Metastasis (2005) 1.20
Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol (2003) 1.20
Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer (2004) 1.18
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem (1999) 1.18
Molecular regulation of the VEGF family -- inducers of angiogenesis and lymphangiogenesis. APMIS (2004) 1.16
Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia (2005) 1.15
Non-angiogenic functions of VEGF in breast cancer. J Mammary Gland Biol Neoplasia (2005) 1.15
Spermidine/spermine N1-acetyltransferase specifically binds to the integrin alpha9 subunit cytoplasmic domain and enhances cell migration. J Cell Biol (2004) 1.10
Role of VEGF family members and receptors in coronary vessel formation. Dev Dyn (2002) 1.06
Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int J Oncol (2006) 1.04
Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res (2003) 1.03
Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. J Biol Chem (2000) 1.00
Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF. Cytokine (2005) 0.99
Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Lett (2006) 0.95
Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest (1999) 0.91
Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor. Exp Cell Res (2003) 0.91
alpha9beta1 integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers. J Leukoc Biol (1999) 0.91
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma. Eur J Surg Oncol (2006) 0.90
Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer (1998) 0.89
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6. Eur J Cancer (2004) 0.87
Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. Lymphat Res Biol (2006) 0.82
Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res (1993) 3.59
Exercise induces recruitment of the "insulin-responsive glucose transporter". Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem (1990) 2.27
Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (1989) 1.96
Randomised controlled trial of thiopental for intubation in neonates. Arch Dis Child Fetal Neonatal Ed (2000) 1.86
Evaluation of the mode of cell death in Ehrlich ascites tumor. Cancer (1972) 1.77
Tuberculosis of the foot. J Bone Joint Surg Br (1999) 1.73
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer (2001) 1.61
Cardiac arrest following stellate ganglion block performed under ultrasound guidance. Anaesthesia (2010) 1.59
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) Am J Cardiol (1996) 1.59
Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol (1998) 1.41
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2. Lancet (1992) 1.40
Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res (1995) 1.40
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer (2006) 1.39
Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate? Contact Dermatitis (1999) 1.39
Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod (1992) 1.30
Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta (1998) 1.30
Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab (2001) 1.29
Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol (1999) 1.22
Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway. J Clin Endocrinol Metab (2001) 1.16
Monoclonal origin of B lymphocyte colony-forming cells in spleen colonies formed by multipotential hemopoietic stem cells. J Exp Med (1978) 1.16
Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.11
Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res (1989) 1.11
Tuberculosis of patella. Knee (2005) 1.10
Mechanism of control of trophoblast invasion in situ. J Cell Physiol (1991) 1.09
Antiulcer activity of Utleria salicifolia rhizome extract. J Ethnopharmacol (2004) 1.09
Maturation of B lymphocytes. I. Concurrent appearance of increasing Ig, Ia, and mitogen responsiveness. J Immunol (1979) 1.08
Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer (1999) 1.08
Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer (2000) 1.08
Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites. Biochem J (2007) 1.08
Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol (1988) 1.06
Localization of H-2 antigens on mouse trophoblast cells. J Exp Med (1979) 1.06
Immunobiology of the feto-maternal interface. Immunol Rev (1983) 1.05
Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J (1992) 1.05
Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol (1986) 1.05
Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol (1993) 1.04
Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res (1998) 1.04
Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology (2008) 1.03
Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leukoc Biol (1988) 1.01
Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses. Clin Exp Immunol (2004) 1.01
Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst (1992) 1.00
Decrease in glucose transporter number in skeletal muscle of mildly diabetic (streptozotocin-treated) rats. Endocrinology (1989) 1.00
Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun (2001) 0.99
Characterization of maternal small lymphocyte subsets during allogeneic pregnancy in the mouse. Cell Immunol (1980) 0.99
Life history of decidual cells: a review. Am J Reprod Immunol (1983) 0.97
Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta (1995) 0.97
Rupture of the thoracic aorta and its relationship to road traffic accident characteristics. Injury (1984) 0.96
Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int J Cancer (1989) 0.96
Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy. Mol Reprod Dev (1992) 0.95
Gastroprotective effect of standardized extract of Ficus glomerata fruit on experimental gastric ulcers in rats. J Ethnopharmacol (2007) 0.95
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer (1996) 0.95
MHC antigens on mouse trophoblast cells: paucity of Ia antigens despite the presence of H-2K and D. J Immunol (1981) 0.95
Measurement of S period in growing cell populations by a graphic analysis of double labeling with 3H- and 14C-thymidine. Exp Cell Res (1968) 0.95
Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res (1994) 0.94
Suppression of lymphocyte alloreactivity by early gestational human decidua. I. Characterization of suppressor cells and suppressor molecules. Cell Immunol (1988) 0.94
Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int J Cancer (1985) 0.93
Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J Exp Med (1987) 0.93
Antifilarial activity of Caesalpinia bonducella against experimental filarial infections. Indian J Med Res (2008) 0.93
PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cell Immunol (1989) 0.92
Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity. Cell Immunol (1985) 0.92
Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta (1995) 0.92
Localization of paternal H-2K antigens on murine trophoblast cells in vivo. J Exp Med (1982) 0.91
The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res (2007) 0.90
Differential gene expression in premalignant human trophoblast: role of IGFBP-5. Int J Cancer (2001) 0.90
HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Mol Hum Reprod (2005) 0.89
Heavy metal pollution among autoworkers. I. Lead. Br J Ind Med (1977) 0.89
Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome. Cancer Metastasis Rev (1998) 0.89
Characterization of urokinase receptor expression by human placental trophoblasts. Blood (1992) 0.89
Recurrent osteoid osteoma: a case report with imaging features. Clin Imaging (2003) 0.88
Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man. J Neurol (2003) 0.88
Characterization of hematogenous cellular constituents of the murine decidua: a surface marker study. J Reprod Immunol (1985) 0.87
SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta. Int J Cancer (1998) 0.87
Bone marrow origin of decidual cell precursors in the pseudopregnant mouse uterus. J Exp Med (1982) 0.87
Effect of seat belts on injuries to front and rear seat passengers. Br Med J (Clin Res Ed) (1985) 0.86
The azo dye solvent yellow 3 produces depigmentation. Contact Dermatitis (2000) 0.86
Outcome in relation to Apgar score in term neonates. Indian Pediatr (1994) 0.86
Interleukin-1 stimulates human chorionic gonadotropin secretion by first trimester human trophoblast. J Clin Endocrinol Metab (1989) 0.86
Melting kinetics in polymers. Phys Rev Lett (2006) 0.86
Classification and treatment of volar Barton fractures. Injury (1993) 0.86
Post-mitotic age of monocuclear cells migrating into TA-3(St) solid tumors. Cell Tissue Kinet (1977) 0.85
Characterization of glucose transporter-enriched membranes from rat skeletal muscle: assessment of endothelial cell contamination and presence of sarcoplasmic reticulum and transverse tubules. Endocrinology (1991) 0.85
Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod (1998) 0.85
Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood. Immunology (1978) 0.85
Dietary and serum iron, body iron stores and coronary heart disease. J Assoc Physicians India (2000) 0.85
Prostaglandin-mediated inactivation of natural killer cells in the murine decidua. Cell Immunol (1990) 0.84
Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: kinetics of hybridization, and concurrent changes in the histocompatiblity profile of the tumor after propagation in different host strains. Eur J Cancer (1980) 0.84
Age-specific changes in the proliferation of Ehrlich ascites tumor cells grown as solid tumors. Cancer Res (1972) 0.84
Statistical evaluation of diluents and automatic diluting and pipetting machines in influenza serology. Appl Microbiol (1971) 0.84
Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer (2001) 0.84
Quantitative histochemical evaluation of normal human skeletal muscle. Neurology (1976) 0.83
Maturation of B lymphocytes. II. Sequential appearance of increasing IgM and IgD in the adult bone marrow. Eur J Immunol (1979) 0.83
The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res (2006) 0.83
Decidual cell-specific surface antigen(s) recognized by monoclonal antibodies: tissue and species distribution. J Immunol (1985) 0.83
Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: growth pattern, markers, and hormone production. Am J Obstet Gynecol (1989) 0.83
Hyperkalemic renal tubular acidosis: effect of furosemide in humans and in rats. Kidney Int (1985) 0.82
Hemopoietic redistribution in tumor-bearing mice. Exp Hematol (1978) 0.82
Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. Cell Immunol (1985) 0.82
Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection. Am J Ther (1999) 0.82
Computed tomography-guided radiofrequency ablation of osteoid osteomas. J Orthop Surg (Hong Kong) (2008) 0.82
Dynamics of leukocyte migration into the mouse ascites tumor. Cell Tissue Kinet (1974) 0.82